Best-fit model for spinal mobility (BASMI).
Entire ankylosing spondylitis population (n=214) | Disease duration ≤3 years (n=53) | Disease duration >3 years (n=161) | |
---|---|---|---|
mSASSS | |||
B | 0.865 | 0.380 | 0.924 |
95% CI | 0.677–1.054 | −0.099 to 0.858 | 0.715–1.134 |
p Value | <0.001 | 0.117 | <0.001 |
ASspiMRI-a | |||
B | 0.236 | 0.595 | 0.156 |
95% CI | 0.041–0.432 | 0.173–1.016 | −0.070 to 0.383 |
p Value | 0.018 | 0.007 | 0.174 |
Gender (male) | |||
B | −0.305 | −0.454 | −0.299 |
95% CI | −0.738 to 0.127 | −1.338 to 0.429 | −0.796 to 0.198 |
p Value | 0.165 | 0.307 | 0.237 |
Results are shown for the entire AS population and according to disease duration.
ASspiMRI-a, Ankylosing Spondylitis spinal MRI activity; B, regression coefficient; BASMI, linear definition of the Bath Ankylosing Spondylitis Metrology Index; mSASSS, modified Stoke Ankylosing Spondylitis Spine Score.